Anthony Langone MD

PubMed

• Disseminated Histoplasmosis Manifesting as Oral Lesions in a Kidney Transplant Patient.
  Sebastian Hinojosa, Kaitlyn Reasoner, Trey Richardson, Levan Gakhokidze, Alissa Ice
  Transplant Infectious Disease. 2025-03-07
• 3 citations
  Emphysematous gastritis due to Sarcina ventriculi infection in an immunocompromised adult.
  Sean E Kisch, Jasmine Walker, Annette E Hebert, Annika L Windon, Kevin Christopher Dee
  Transplant Infectious Disease. 2024-02-01
• 1 citations
  Twelve-month kidney and liver outcomes of kidney transplantation from Hepatitis C Viremic deceased donors to aviremic recipients.
  Laura A Binari, Peter Thorne, Scott A Rega, Irene D Feurer, Saed Shawar
  Transplant Infectious Disease. 2024-02-01

Journal Articles

• Reduced BK Virus Nephropathy but Increased Acute Rejection with Mycophenolate Mofetil Dose Reduction in Kidney Transplantation.  
  Shaffer D, Langone A, Nylander W A, Kizilisik T, Helderman J H, Graft; 7(1); 31-32

Books/Book Chapters

• The Kidney Physiology and Pathophysiology. 
  Chapter: Homeostasis of Solute and Water by the Transplanted Kidney 
  Page 2737 - 2761Helderman JH, Schaefer H, Langone A, Goral SSeldin & GiebischEdition 4th,
• Nissenson & Fine: Dialysis Therapy. 
  Chapter: End-Stage Renal Failure in the Diabetic Patient 
  Page 1061 - 1075Giullian J, Langone AJEdition 4th,
• Medical Management of the Renal Transplant Recipient. 
  Chapter: Immunosuppression 
  Page 127 - 137Langone AJ, Helderman JHEditors: Weir M.Edition 1st,
• Current Therapy in Allergy Immunology & Rheumatology. 
  Chapter: Therapeutic Approach to Renal Transplantation 
  Page 130 - 134Langone AJ, Helderman JHLichtenstein, Busse & Geha, LichtensteinEdition 6th,
• Kidney Transplantation. 
  Chapter: Immunosuppressive Drug Therapy 
  Page 39 - 54LangoneAJ, Helderman JHHricik
• Comprehensive Clinical Nephrology. 
  Chapter: Prophylaxis and Treatment of Renal Transplant Rejection 
  Page 1093 - 1103Ramanathan V, Langone AJJohnson & FeehallyEdition 2nd,
• Dialysis Therapy. 
  Chapter: Hemodialysis for End Stage Diabetic Nephropathy 
  Page 425 - 429Langone AJ, Lewis JNissenson & FineEdition 3rd,
• Principles and Practice of Renal Transplantation. 
  Page 1439 - 1440Langone AJ, Helderman JHKahan& Ponticelli’s
• Join now to see all

Abstracts/Posters

• Mycophenolic Acid (MPA) Therapy in Diabetic Kidney Transplant Patients: An Analysis of the MORE Registry.
  Irish W, Doria C, Greenstein S, Chan L, Narayanan M, Ueda K, Sankari B, Langone A, ASN
• Inadequate Dobutamine Stress Echo Based on Target Heart Rate in Patients with ESRD Presenting for Transplantation: Is Cardiac Catherization Necessary?
  Schaefer H, Langone A, Helderman JH, Am Soc Nephrol 16
• High Prevalence of Erectile Dysfunction After Kidney Pancreas Transplantation.
  Butler L, Shaffer D, Feurer I, Langone AJ, Helderman JH, Kizilisik AT, Nylander WA, Schaefer HM, WTC
• Short-Term Results Under Three Different Immunosuppressive Regimens at One Center.
  Schaefer HM, Kizilisik AT, Feurer I, Langone AJ, Helderman JH, Nylander WA, Shaffer D, WTC
• Calcineurin Inhibitor Avoidance VS Steroid Avoidance Following Kidney Transplantation: Post-Operative Complications.
  18. Shaffer D, Kizilisik AT, Helderman JH, Langone AJ, Nylander WA, Feurer I, Schaefer HM, WTC
• Preliminary Results of Early Steroid Withdrawal in African American Patients Undergoing Kidney Transplantation.
  Schaefer HM, Feurer I, Helderman JH, Langone AJ, Kizilisik AT, Nylander WA, Shaffer D, WTC
• Calcineurin Inhibitor Avoidance in Kidney Transplantation: A Prospective, Randomized, Single-Center Trial of Sirolimus Versus Tacrolimus with Thymoglobulin Induction.
  Shaffer D, Schaefer HM, Feurer I, Helderman JH, Langone AJ, Nylander WA, WTC
• A Non Randomized, Retrospective Review of Simulect Versus Thymoglobulin As Induction Agents for Kidney Transplantation at a Single Transplant Center.
  Chuang P, Buchanan C, Kizilisik T, Schaefer H, Chakravarty A, Helderman JH, Nylander W, Shaffer D, Langone AJ, WTC
• The Rate and Risk Factors Associated with Bone Fractures in Renal Transplant Patients.
  Langone AJ, Gray J, Buchanan C, Schaefer H, Helderman JH, Shaffer D, Kizilisik T, Nylander W, Chuang P, WTC
• Conversion from Tacrolimus to Cyclosporine and Withdrawal of Mycophenolate Mofetil in Polyoma Nephropathy Patients.
  Chakravarty A, Schaefer H, Helderman JH, Shaffer D, Langone A, WTC
• The Utility of Immunofluorescence and Electron Microscopy in Renal Transplant Biopsies.
  Langone AJ, Nitschke A, Helderman JH, Schaefer H, Nylander W, Shaffer D, Kizilisik T, Chuang P, Moeckel G, Fogo A, WTC
• Steroid Avoidance in African American Patients Undergoing Kidney Transplantation.
  Schaefer H, Sakai L, Feurer I, Buchanon C, Langone A, Helderman J, Nylander W, Shaffer D, WTC
• The Mycophenolic Acid Observational Renal Transplant Study (MORE) Registry: Summary of Patient Management in De Novo Renal Transplantation.
  Irish W, Greenstein S, Doria C, Chan L, Narayanan M, Ueda K, Langone A, WTC
• Conversion from Mycophenolate Mofetil (MMF) to Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Recipients with Diabetes Mellitus.
  Langone A, Chan L, Wiland A, McCague K, Bolin P, Cooper M, ASN
• C4d Staining and Donor Specific Antibodies in Renal Allografts: Diagnostic and Therapeutic Implications.
  Schaefer H, Langone A, Kizilisik T, Nylander W, Shaffer D, Moeckel G, Fogo A, Crowe D, Helderman JH, J Am Soc Nephrol 16
• Mycophenoic Acid (MPA) Therapy in Kidney Transplantation: An Analysis of the MORE Registry.
  Irish W, Doria C, Greenstein S, Chan L, Narayanan M, Ueda K, Sankari B, Langone A, ASN
• Early Adherence with Immunosuppressant Medications: One-Year Analysis of the Mycophenolic Acid Observational Renal Transplant (MORE) Registry.
  M. Chisholm-Burns, L. Chan, A. Langone, J. Wang, P. Lake, W. Irish, ATC
• Early Outcome Analysis of the Mycophenolic Acid Observational Renal Transplant (MORE) Registry: Initial Comparisons of Enteric-Coated Mycophenolate Sodium and Mycophen...
  A. Langone, L. Chan, S. Greenstein, R. Carson, A. Wiland, K McCague, C Doria, ATC
• The Prevalence of Patients Referred for Renal Transplantation that have Achieved Age Appropriate Standard of Care Cancer Screening Including Colonoscopy, Mammography, ...
  A. Langone, S. Walters, H. Schaefer, D. Hale, D. Shaffer, S. Bala, B. Concepcion, JH Helderman, ATC
• A Calcineurin Free Protocol for Patients with Delayed Graft Function and for Recipients of Marginal Donor Kidneys.
  Shaffer D, Langone A, Nylander, W, et. al, Poster AST
• Obesity does not Increase the Risk of Early Complications Following Living Donor Kidney Transplantation.
  Shaffer D, Nylander WA, Kizilisik T, Langone A, Helderman JH, Poster AST
• Renal Transplantation Improves Biomarkers of Oxidative Stress in Patients with End-Stage Renal Disease (ESRD).
  Simmons E, Langone A, Recupero P, et al, Poster ASN
• The Preceding Symptomatology, Histology and Prevalence Rate of Renal Transplant Nephrectomies.
  Langone AJ, Karipidis M, Meyer J, et al, Poster ASN
• Living Kidney Donation: Prevalence and Etiology of Potential Donor Unsuitability.
  Langone, AJ, Fischbach, B, Ray, J et al, Poster Presentation ASN
• Reduced Risk of BK Virus but Increased Risk of Rejection with Mycophenolate Mofetil Dose Reduction Following Kidney Transplantation.
  Shaffer D, Nylander WN, Kizilisik T, Helderman JH, Langone A, Poster Presentation AST
• The Effect of CREG Matching on Graft Survival and HLA Sensitization in Renal Transplant Recipients.
  Crowe D, Langone A, Shaffer D, Kizilisik T, Nylander WN, Helderman JH, Oral Presentation AST
• Urinary Tract Infections Increase the Risk of Mortality After Renal Transplantation.
  Chuang P, Ray J, Edmondson B, Shaffer D, Kizilisik T, Nylander WN, Helderman JH, Langone A, Oral Presentation AST
• Join now to see all

Lectures

• Management of the Failing and Failed Renal Transplant. 
  National Kidney Foundation, Las Vegas
• Are We Failing to Adequately Care for Patients with Failing Kidney Transplants? 
  American Society of Nephrology, Denver
• Early Adherence with Immunosuppressant Medications: One-Year Analysis of the Mycophenolic Acid Observational Renal Transplant (MORE) Registry. 
  American Transplant Congress, San Diego
• Improving Renal Transplant Outcomes: Sharing Best Practice from the US. 
  Multiple locations, 2006, 2008
• Hypertension, Diabetes and Nephropathy. & Improving Renal Transplant Outcomes: Sharing Best Practice from the US. 
  Advances in Medicine Conference. University of the West Indies. Jamaica, WVI
• Approach to the Sensitized Patient. 
  Nurse Practitioners Transplant Symposium, Nashville, Tennessee
• Hypertension in renal transplantation. 
  Nurse Practitioners Transplant Symposium, Nashville, Tennessee
• Preparing Your Patient for Renal Transplantation. 
  National Kidney Foundation of Tennessee Conference, Memphis, Tennessee
• Optimizing Renal Transplant Outcomes: How Can We Prolong the Magic? 
  Multiple locations, 2006
• Management of Post-Transplantation Bone Disease. 
  Multiple locations, 2004
• Chronic Allograft Nephropathy: Redefining the pathology. 
  Multiple locations, 2004
• Current Issues in IL-2 Receptor Monoclonal Antibody Therapy. 
  Multiple locations, 2004
• Hypertension, Diabetes and Resultant Nephropathy: The Role of Angiotensin Receptor Blockers. 
  5th Annual Primary Care Forum. Blount County Medical Society. Oneonta, Alabama
• Post Transplantation Diabetes. 
  St. Luke’s Hospital, Milwaukee Wisconsin
• Join now to see all